Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?

The New York Times – Business:

Janssen Pharmaceuticals ended a global trial after independent experts determined the vaccine was not effective. But there are other possibilities in the pipeline, scientists said.

Apoorva Mandavilli
Author: Apoorva Mandavilli

This post first appeared in The New York Times – Business. Read the original article.

Written by

Apoorva Mandavilli

in

Drugs (Pharmaceuticals), Europe, Gender, Janssen Pharmaceutica, Johnson & Johnson, North America, South America, Vaccination and Immunization, Viruses
←Russian Citizen Accused of Running Cryptocurrency Exchange Used by Criminals
In Philadelphia, a Cocktail Bar With Bold Colors and Swedish Meatballs→

More posts

  • Netflix’s Dan Brown TV Adaptation Of ‘The Secret of Secrets’ Rounds Out Cast, Releases First Look As Production Begins

  • ‘Harry Potter’ Finds Its New Ginny Weasley, Casts Tom Riddle & Dobby Roles In HBO Series Season 2

  • Planes grounded at Gatwick after aircraft stuck on runway

  • Former podcaster charged for death threats against Trump

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube